Drugs for Relapse Prevention of Alcoholism gives a comprehensive overview about different neurotransmitter/peptide systems involved in craving and relapse behavior and critically describes the clinical application of new anti-craving and anti-relapse compounds.

Drugs for Relapse Prevention of Alcoholism sets out to provide an all-encompassing overview about the topic, which will be of interest to the preclinical researcher, the clinician as well as to the patient who wants to learn more.

Contents

1. History of Prevention of Relapse
2. How to Measure Relapse in Animals
3. How to Measure Relapse in Humans
4. Disulfiram: the First Medication to Stop Drinking
5. Naltrexone: Preclinical Data
6. Naltrexone: Clinical Data
7. Acamprosate: Preclinical Data
8. Acamprosate: Clinical Data
9. Serotonergic Compounds: Preclinical Data
10. Serotonergic Compounds: Clinical Data
11. Opioidergic Compounds: Preclinical Data
12. Second Generation Opioidergic Compounds: Clinical Data
13. Dopaminergic Compounds: Preclinical data
14. Baclofen: Preclinical Data
15. Baclofen: Clinical Data
16. Cannabinoid Receptor Antagonists: A Perspective
17. Neuropeptide Y Antagonists: A Perspective
18. Glutamatergic Compounds: A Perspective
19. Future Perspectives on Relapse Prevention

Index

click here to see books • videos • cd-roms of related interest